Frans Van de Werf

Frans Van de Werf is a Belgian cardiologist at the University Hospital Leuven and a professor of medicine at the Katholieke Universiteit Leuven. He was the chair of the university hospital's cardiovascular medicine department until 2011. His research is focused on acute coronary syndromes, thrombolysis and antithrombotic treatment. His doctoral thesis was an early treatise on the mechanism underlying the gallop rhythm in heart failure. Later, he collaborated in Leuven with Désiré Collen to discover the clinical application of tissue plasminogen activator (tPA).

Frans Van de Werf

Frans Van de Werf is a Belgian cardiologist at the University Hospital Leuven and a professor of medicine at the Katholieke Universiteit Leuven. He was the chair of the university hospital's cardiovascular medicine department until 2011. His research is focused on acute coronary syndromes, thrombolysis and antithrombotic treatment. His doctoral thesis was an early treatise on the mechanism underlying the gallop rhythm in heart failure. Later, he collaborated in Leuven with Désiré Collen to discover the clinical application of tissue plasminogen activator (tPA).